Total Payments
$23,430
2024 Payments
$3,325
Companies
40
Transactions
342
Medicare Patients
7,078
Medicare Billing
$871,836
Payment Breakdown by Category
Food & Beverage$12,045 (51.4%)
Other$3,950 (16.9%)
Consulting$3,600 (15.4%)
Research$2,027 (8.7%)
Travel$1,623 (6.9%)
Gifts$144.99 (0.6%)
Education$39.95 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,045 | 316 | 51.4% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $3,950 | 5 | 16.9% |
| Consulting Fee | $3,600 | 4 | 15.4% |
| Unspecified | $2,027 | 8 | 8.7% |
| Travel and Lodging | $1,623 | 6 | 6.9% |
| Gift | $144.99 | 2 | 0.6% |
| Education | $39.95 | 1 | 0.2% |
Payments by Type
General
$21,403
334 transactions
Research
$2,027
8 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Oasis Medical, Inc. | $3,950 | 5 | $0 (2017) |
| ABBVIE INC. | $2,743 | 35 | $0 (2024) |
| Alcon Vision LLC | $2,586 | 54 | $0 (2024) |
| Glaukos Corporation | $2,222 | 11 | $0 (2023) |
| Allergan, Inc. | $1,780 | 39 | $0 (2022) |
| Kala Pharmaceuticals, Inc. | $1,572 | 10 | $0 (2022) |
| Alcon Laboratories Inc | $1,279 | 18 | $0 (2018) |
| Ivantis, Inc | $1,200 | 14 | $0 (2021) |
| Johnson & Johnson Surgical Vision, Inc. | $829.23 | 18 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $814.57 | 27 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,325 | 52 | ABBVIE INC. ($2,221) |
| 2023 | $3,905 | 50 | Alcon Vision LLC ($1,261) |
| 2022 | $2,278 | 52 | GLAUKOS CORPORATION ($998.56) |
| 2021 | $3,442 | 43 | Kala Pharmaceuticals, Inc. ($1,368) |
| 2020 | $596.46 | 27 | Ivantis, Inc ($156.37) |
| 2019 | $1,803 | 39 | Alcon Vision LLC ($454.31) |
| 2018 | $2,485 | 42 | Alcon Laboratories Inc ($1,130) |
| 2017 | $5,597 | 37 | Oasis Medical, Inc. ($3,950) |
All Payment Transactions
342 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $17.22 | General |
| Category: EYE CARE | ||||||
| 12/11/2024 | Johnson & Johnson Surgical Vision, Inc. | TECNIS IOL (Device) | Food and Beverage | In-kind items and services | $49.03 | General |
| Category: Optics | ||||||
| 12/11/2024 | Alcon Vision LLC | Clareon (Device) | Food and Beverage | In-kind items and services | $7.25 | General |
| Category: Ophthalmology | ||||||
| 11/15/2024 | Alcon Vision LLC | Rocklatan (Drug) | Food and Beverage | In-kind items and services | $6.32 | General |
| Category: Ophthalmology | ||||||
| 11/12/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: Ophthalmology | ||||||
| 10/30/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: Ophthalmology | ||||||
| 10/23/2024 | Alcon Vision LLC | Clareon (Device) | Food and Beverage | In-kind items and services | $26.70 | General |
| Category: Ophthalmology | ||||||
| 10/21/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $18.51 | General |
| Category: EYE CARE | ||||||
| 09/27/2024 | Harrow Eye, LLC | VEVYE (Drug) | Food and Beverage | In-kind items and services | $9.20 | General |
| Category: OPTOMETRY | ||||||
| 09/27/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $5.37 | General |
| Category: EYE CARE | ||||||
| 09/22/2024 | ABBVIE INC. | — | — | In-kind items and services | $637.98 | Research |
| Study: A Phase 1/2 Study to Evaluate the Safety and Efficacy of AGN-193408 SR in Participants With Open-Angle Glaucoma or Ocular Hypertension | ||||||
| 09/22/2024 | ABBVIE INC. | — | — | In-kind items and services | $512.71 | Research |
| Study: A Phase 1/2 Study to Evaluate the Safety and Efficacy of AGN-193408 SR in Participants With Open-Angle Glaucoma or Ocular Hypertension | ||||||
| 09/21/2024 | ABBVIE INC. | — | — | In-kind items and services | $348.25 | Research |
| Study: A Phase 1/2 Study to Evaluate the Safety and Efficacy of AGN-193408 SR in Participants With Open-Angle Glaucoma or Ocular Hypertension | ||||||
| 09/21/2024 | ABBVIE INC. | — | — | In-kind items and services | $69.99 | Research |
| Study: A Phase 1/2 Study to Evaluate the Safety and Efficacy of AGN-193408 SR in Participants With Open-Angle Glaucoma or Ocular Hypertension | ||||||
| 09/21/2024 | ABBVIE INC. | — | — | In-kind items and services | $59.99 | Research |
| Study: A Phase 1/2 Study to Evaluate the Safety and Efficacy of AGN-193408 SR in Participants With Open-Angle Glaucoma or Ocular Hypertension | ||||||
| 09/21/2024 | ABBVIE INC. | — | — | In-kind items and services | $25.00 | Research |
| Study: A Phase 1/2 Study to Evaluate the Safety and Efficacy of AGN-193408 SR in Participants With Open-Angle Glaucoma or Ocular Hypertension | ||||||
| 09/21/2024 | ABBVIE INC. | — | — | In-kind items and services | $25.00 | Research |
| Study: A Phase 1/2 Study to Evaluate the Safety and Efficacy of AGN-193408 SR in Participants With Open-Angle Glaucoma or Ocular Hypertension | ||||||
| 09/20/2024 | ABBVIE INC. | — | — | In-kind items and services | $348.25 | Research |
| Study: A Phase 1/2 Study to Evaluate the Safety and Efficacy of AGN-193408 SR in Participants With Open-Angle Glaucoma or Ocular Hypertension | ||||||
| 09/19/2024 | Alcon Vision LLC | HYDRUS Microstent (Device) | Food and Beverage | In-kind items and services | $133.85 | General |
| Category: Ophthalmology | ||||||
| 09/18/2024 | Harrow Eye, LLC | VEVYE (Drug) | Food and Beverage | In-kind items and services | $24.77 | General |
| Category: OPTOMETRY | ||||||
| 09/13/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: Ophthalmology | ||||||
| 08/27/2024 | Alcon Vision LLC | Clareon (Device) | Food and Beverage | In-kind items and services | $20.32 | General |
| Category: Ophthalmology | ||||||
| 08/27/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $18.12 | General |
| Category: EYE CARE | ||||||
| 08/19/2024 | Alcon Vision LLC | HYDRUS Microstent (Device) | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: Ophthalmology | ||||||
| 08/12/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug), MIEBO | Food and Beverage | In-kind items and services | $18.39 | General |
| Category: Ophthalmology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A Phase 1/2 Study to Evaluate the Safety and Efficacy of AGN-193408 SR in Participants With Open-Angle Glaucoma or Ocular Hypertension | ABBVIE INC. | $2,027 | 8 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,934 | 2,506 | $1.0M | $236,057 |
| 2022 | 16 | 1,754 | 2,199 | $949,165 | $207,472 |
| 2021 | 17 | 1,819 | 2,267 | $1.0M | $231,020 |
| 2020 | 20 | 1,571 | 2,070 | $868,531 | $197,287 |
Total Patients
7,078
Total Services
9,042
Medicare Billing
$871,836
Procedure Codes
71
All Medicare Procedures & Services
71 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2023 | 132 | 208 | $376,585 | $86,081 | 22.9% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 403 | 801 | $206,225 | $50,733 | 24.6% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 396 | 403 | $149,185 | $34,158 | 22.9% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Facility | 2023 | 87 | 115 | $112,700 | $26,760 | 23.7% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 153 | 156 | $30,420 | $6,844 | 22.5% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2023 | 175 | 182 | $41,105 | $5,782 | 14.1% |
| 92133 | Imaging of optic nerve | Office | 2023 | 195 | 200 | $23,000 | $5,005 | 21.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 44 | 44 | $21,780 | $4,217 | 19.4% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 33 | 33 | $14,685 | $3,569 | 24.3% |
| 68761 | Closure of tear duct opening using plug | Office | 2023 | 16 | 27 | $11,779 | $2,536 | 21.5% |
| 65855 | Laser repair to improve eye fluid flow | Facility | 2023 | 11 | 13 | $13,120 | $2,395 | 18.3% |
| 92025 | Ct scan of cornea | Office | 2023 | 87 | 100 | $11,390 | $2,347 | 20.6% |
| 92134 | Imaging of retina | Office | 2023 | 61 | 62 | $7,750 | $1,717 | 22.2% |
| 92071 | Fitting of contact lens for treatment of eye surface disease | Office | 2023 | 17 | 37 | $5,905 | $1,213 | 20.5% |
| 92286 | Imaging of front third of eye using a special microscope | Office | 2023 | 37 | 37 | $4,255 | $1,063 | 25.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 13 | 13 | $4,245 | $865.36 | 20.4% |
| 76514 | Ultrasound scan of cornea to determine thickness | Office | 2023 | 56 | 57 | $2,655 | $468.15 | 17.6% |
| 92020 | Exam of the internal drainage system of eye | Office | 2023 | 18 | 18 | $1,530 | $305.48 | 20.0% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2022 | 125 | 200 | $383,000 | $80,904 | 21.1% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 339 | 610 | $155,540 | $37,695 | 24.2% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 366 | 377 | $139,490 | $31,601 | 22.7% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Facility | 2022 | 79 | 106 | $103,880 | $25,339 | 24.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 56 | 56 | $27,720 | $5,744 | 20.7% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 121 | 123 | $23,985 | $5,304 | 22.1% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2022 | 152 | 158 | $41,870 | $5,287 | 12.6% |
About Dr. Mujtaba Qazi, M.D
Dr. Mujtaba Qazi, M.D is a Ophthalmology healthcare provider based in Chesterfield, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/22/2005. The National Provider Identifier (NPI) number assigned to this provider is 1124010434.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mujtaba Qazi, M.D has received a total of $23,430 in payments from pharmaceutical and medical device companies, with $3,325 received in 2024. These payments were reported across 342 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($12,045).
As a Medicare-enrolled provider, Qazi has provided services to 7,078 Medicare beneficiaries, totaling 9,042 services with total Medicare billing of $871,836. Data is available for 4 years (2020–2023), covering 71 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Location Chesterfield, MO
- Active Since 08/22/2005
- Last Updated 08/11/2017
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1124010434
Products in Payments
- Intacs Intracorneal Ring Segments (Device) $2,950
- EYSUVIS (Drug) $1,307
- KXL system (not refurbished) (Device) $1,050
- Hydrus Microstent (Device) $1,044
- Intacs Intracorneal ring segments (Device) $1,000
- DURYSTA (Drug) $982.28
- ILINK (Device) $750.00
- XIIDRA (Drug) $616.82
- HYDRUS Microstent (Device) $563.42
- ACTHAR (Biological) $495.89
- DAILIES (Device) $432.23
- LUMIGAN (Drug) $407.51
- VYZULTA (Drug) $404.47
- AcrySof (Device) $331.02
- Cequa (Drug) $296.95
- INVELTYS (Drug) $272.30
- ReSTOR (Device) $262.74
- Kahook Dual Blade (Device) $257.06
- KXL SYSTEM (Device) $248.56
- Oxervate (Drug) $217.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Chesterfield
Dr. Nancy Holekamp, M.d, M.D
Ophthalmology — Payments: $1.2M
Ophthalmology $1.2M
Dr. Paul Tesser, Md, MD
Ophthalmology — Payments: $72,842
Ophthalmology $72,842
Dr. Ibrahim Sayed-Ahmed, Md Ms, MD MS
Ophthalmology — Payments: $7,251
Ophthalmology $7,251
Dr. Farheen N Kazi Raja, M.d, M.D
Ophthalmology — Payments: $3,631
Ophthalmology $3,631
Jonathan Crews, D.o, D.O
Ophthalmology — Payments: $1,778
Ophthalmology $1,778
Dr. Whitney Brothers, M.d, M.D
Ophthalmology — Payments: $1,395
Ophthalmology $1,395